Call for Papers: Drugging cancer vulnerabilities toward innovative clinical trials
Journal of Experimental & Clinical Cancer Research is delighted to announce the new thematic series covering the actual knowledge of novel strategies on anticancer treatments.
The Special Issue will accept Research Articles and Reviews regarding the latest highlights on Drugging cancer vulnerabilities toward innovative clinical trials. Submit here.
- Submission opens: 1st April 2021
- Submission deadline: 31st December 2021
Click here to view this collection. Click here to access all thematic series published to date in Journal of Experimental & Clinical Cancer Research.
Recognising Editorial Excellence
Journal of Experimental & Clinical Cancer Research is a top rated Springer Nature journal. Prof. Mauro Castelli and the editorial team performed in the top percentile of journals based on data collected from the Journal Author Satisfaction Survey. We are recognising extraordinary editors for their commitment and passion to their journals. Read more about editorial excellence here.
Impact of COVID-19 on journal operations
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
We are trying our best to work through this crisis as efficiently and effectively as possible and thank you for your support and patience during these challenging times.
Thumbnail image by Felipe Esquivel Reed, used under Creative Commons Attribution-Share Alike 4.0 license.
Celebrating the 10th anniversary partnership with BMC
2018 marks the 10th anniversary of the partnership between the Journal of Experimental & Clinical Cancer Research and BMC.
Over the past decade, the journal has established itself among some of the top Oncology titles in Journal Citation Reports. Click here to look back at some of the journal’s milestone achievements and best content from the past 10 years.
Reviewer Acknowledgement and New Recruitment
The Editor-in-Chief of Journal of Experimental & Clinical Cancer Research would like to thank all of our reviewers who have contributed to the journal and is looking for new reviewers to assess manuscripts. For consideration, please send your CV with keywords and expertise to email@example.com
Journal of Experimental & Clinical Cancer Research has been publishing since 1982. Prior to publishing with BioMed Central from 2008, Journal of Experimental & Clinical Cancer Research was published in print. For enquiries about previous content, please contact us on: